Getinge AB (GNGBY)
25.74
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Getinge EPS Diluted (Quarterly) : 0.3297 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3297 |
| March 31, 2026 | 0.1611 |
| December 31, 2025 | 0.3388 |
| September 30, 2025 | 0.2183 |
| June 30, 2025 | 0.1991 |
| March 31, 2025 | 0.1032 |
| December 31, 2024 | 0.2261 |
| September 30, 2024 | 0.0007 |
| June 30, 2024 | 0.1762 |
| March 31, 2024 | 0.1621 |
| December 31, 2023 | 0.2471 |
| September 30, 2023 | 0.3036 |
| June 30, 2023 | 0.0745 |
| March 31, 2023 | 0.2061 |
| December 31, 2022 | 0.1903 |
| September 30, 2022 | 0.2777 |
| June 30, 2022 | 0.2248 |
| March 31, 2022 | 0.2099 |
| December 31, 2021 | 0.3194 |
| September 30, 2021 | 0.3214 |
| June 30, 2021 | 0.3483 |
| March 31, 2021 | 0.2814 |
| December 31, 2020 | 0.4664 |
| September 30, 2020 | 0.5714 |
| June 30, 2020 | 0.1874 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1028 |
| December 31, 2019 | 0.3455 |
| September 30, 2019 | 0.0796 |
| June 30, 2019 | 0.04 |
| March 31, 2019 | 0.0024 |
| December 31, 2018 | 0.2894 |
| September 30, 2018 | -0.5967 |
| June 30, 2018 | 0.0346 |
| March 31, 2018 | -0.1393 |
| December 31, 2017 | 0.4615 |
| September 30, 2017 | 0.0245 |
| June 30, 2017 | 0.0011 |
| March 31, 2017 | 0.1271 |
| December 31, 2016 | 0.4315 |
| September 30, 2016 | -0.0416 |
| June 30, 2016 | 0.1116 |
| March 31, 2016 | 0.0536 |
| December 31, 2015 | 0.4662 |
| September 30, 2015 | 0.0848 |
| June 30, 2015 | 0.0832 |
| March 31, 2015 | 0.0449 |
| December 31, 2014 | 0.5505 |
| September 30, 2014 | 0.2185 |
| June 30, 2014 | 0.2493 |
| March 31, 2014 | -0.212 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Xvivo Perfusion AB | 0.0552 |
| Paxman AB | 0.0117 |
| Enovis Corp. | -0.0207 |
| Edwards Lifesciences Corp. | 0.4188 |
| Intuitive Surgical, Inc. | 2.290 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 89.59M |
| Revenue (Quarterly) | 894.98M |
| Total Expenses (Quarterly) | 805.18M |
| Enterprise Value | 7.482B |
| Gross Profit Margin (Quarterly) | 49.35% |
| Profit Margin (Quarterly) | 10.01% |
| Earnings Yield | 4.07% |
| Operating Earnings Yield | 7.06% |
| Normalized Earnings Yield | 4.253 |